Convective Radiofrequency Water Vapor Thermal Therapy with Rezūm System

[1]  C. Roehrborn,et al.  Convective Thermal Therapy: Durable 2‐Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia , 2017, The Journal of urology.

[2]  C. Roehrborn,et al.  CONVECTIVE RADIOFREQUENCY THERMAL THERAPY: DURABLE TWO‐YEAR OUTCOMES OF A RANDOMIZED CONTROLLED AND PROSPECTIVE CROSSOVER STUDY TO RELIEVE LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: PD23‐10 , 2017 .

[3]  D. Pacík,et al.  Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia , 2016, Research and reports in urology.

[4]  C. Roehrborn,et al.  Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. , 2016, The journal of sexual medicine.

[5]  C. Roehrborn,et al.  Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2016, The Journal of urology.

[6]  B. Helfand,et al.  Analyzing Why Men Seek Treatment for Lower Urinary Tract Symptoms and Factors Associated With Nonimprovement. , 2015, Urology.

[7]  D. Pacík,et al.  Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2015, Urology.

[8]  R. Autorino,et al.  Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. , 2015, European urology.

[9]  Igor Sorokin,et al.  Placebo Medication and Sham Surgery Responses in Benign Prostatic Hyperplasia Treatments: Implications for Clinical Trials , 2015, Current Urology Reports.

[10]  R. Robb,et al.  Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings. , 2015, Urology.

[11]  C. Roehrborn,et al.  PII-LBA1 USING THE THERMAL ENERGY OF CONVECTIVELY DELIVERED WATER VAPOR FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: THE REZUM II STUDY , 2015 .

[12]  L. Mynderse,et al.  Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostate , 2015, Research and reports in urology.

[13]  Homero Bruschini,et al.  Nocturia is the Lower Urinary Tract Symptom With Greatest Impact on Quality of Life of Men From a Community Setting , 2014, International neurourology journal.

[14]  F. Bruyère,et al.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. , 2014, European urology.

[15]  D. Pacík,et al.  PD26-09 TRANSURETHRAL WATER VAPOR THERAPY FOR BPH; 1-YEAR CLINICAL RESULTS OF THE FIRST-IN-MAN AND REZūM® I CLINICAL TRIALS USING THE REZūM® SYSTEM , 2014 .

[16]  野村 博之.  Photoselective Vaporization of the Prostate (PVP) (特集 薬物治療抵抗性の前立腺肥大症) -- (外科治療) , 2014 .

[17]  C. Roehrborn,et al.  The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia : The L , 2014 .

[18]  R. Dmochowski,et al.  A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. , 2012, European urology.

[19]  T. Wilt,et al.  Microwave thermotherapy for benign prostatic hyperplasia. , 2012, The Cochrane database of systematic reviews.

[20]  M. N. Özişik,et al.  Heat Conduction Fundamentals , 2012 .

[21]  M. N. Özişik,et al.  Heat Conduction: Hahn/Heat Conduction 3e , 2012 .

[22]  H. Mosli,et al.  Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study , 2012 .

[23]  C. Roehrborn,et al.  Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. , 2012, The Journal of urology.

[24]  Victor E Reuter,et al.  Anatomy of the prostate revisited: implications for prostate biopsy and zonal origins of prostate cancer , 2012, Histopathology.

[25]  J. Fitzpatrick,et al.  Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia , 2012, BJU international.

[26]  C. Roehrborn,et al.  Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. , 2011, European urology.

[27]  John T. Wei,et al.  Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.

[28]  T. Wilt,et al.  Progression of lower urinary tract symptoms in older men: a community based study. , 2010, The Journal of urology.

[29]  Tara K. Knight,et al.  Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. , 2009, The Journal of urology.

[30]  John T. Wei,et al.  Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. , 2009, Urology.

[31]  C. Roehrborn.  Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. , 2008, Reviews in urology.

[32]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[33]  P. Teillac,et al.  Characteristics of patients presenting with LUTS/BPH in six European countries. , 2006, European urology.

[34]  C. Bouza,et al.  Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia , 2006, BMC urology.

[35]  Harald Walach,et al.  The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials – A secondary analysis , 2005, BMC medical research methodology.

[36]  John T. Wei,et al.  Urologic diseases in America project: benign prostatic hyperplasia. , 2005, The Journal of urology.

[37]  J. Logie,et al.  Incidence, prevalence and management of lower urinary tract symptoms in men in the UK , 2005, BJU international.

[38]  J C Bischof,et al.  In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia , 2004, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[39]  E. Kursh,et al.  Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. , 2003, Urology.

[40]  A. Unsal,et al.  Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. , 2003, Journal of endourology.

[41]  H. Nielsen,et al.  Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia , 2002, BJU international.

[42]  N. Terada,et al.  Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. , 2000, The Journal of urology.

[43]  Sue-Jane Wang,et al.  Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.

[44]  J. Oesterling,et al.  A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. , 1998, The Journal of urology.

[45]  M. Barry,et al.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? , 1995, The Journal of urology.

[46]  J. McNeal.  The zonal anatomy of the prostate , 1981, The Prostate.